 | |||||
| cannabidiol for epilepsy | |||||
| NEWS | |||||
| GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency ... ... (cannabidiol) oral solution, for the treatment of seizures associated with ... (TSC), a rare genetic condition and a leading cause of genetic epilepsy.
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
